Drug Profile
LiquiVent gene delivery systems - Alliance Pharmaceutical Corporation
Alternative Names: LiquiVent®Latest Information Update: 02 Feb 2007
Price :
$50
*
At a glance
- Originator Alliance Pharmaceutical Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory tract disorders
Most Recent Events
- 02 Feb 2007 Discontinued - Preclinical for Respiratory tract disorders in USA (unspecified route)
- 29 Jun 2001 Preclinical development for Respiratory tract disorders in USA (Unknown route)